Observational Cross-Sectional Study to Assess the Dysnatremia in Patients with Chronic Liver Disease
Authors/Creators
- 1. Senior Resident, Department of Medicine, Darbhanga Medical College and Hospital, Darbhanga, Bihar, India
- 2. Associate professor, Department of Medicine, Darbhanga medical College and Hospital, Darbhanga, Bihar, India
Description
Aim: To study the prevalence of hyponatremia in patients with chronic liver disease attending the outpatient department of a tertiary care hospital. Methodology: An observational cross-sectional study was conducted in the department of medicine, Darbhanga Medical College and Hospital, Darbhanga, Bihar for one year .In this study, patients in the age group of 18 to 65 years were included irrespective of gender, diagnosed with chronic liver disease. A history, physical examination, biochemical markers, ultrasonography, and upper gastrointestinal endoscopy were used to identify cirrhosis. Child-Turcotte Pugh score (CPS) and model for end stage liver disease (MELD) score was calculated for all patients [16]. Those with serum sodium levels less than or equal to 130 meq/l were classified as group A, those with serum sodium levels between 131-135 meq/l as group B and those with serum sodium levels greater than or equal to 136 meq/l as group C. Descriptive analysis of quantitative parameters was expressed as means and standard deviation. Results: In the present study, 100 patients were included. It was observed that 32% were in group A (≤ 130 mEq/l), 34% were in group B (131 to 135 mEq/l) and 34% were in group C (≥ 136 mEq/l). The age or gender of the patients was not associated with serum sodium levels. It was observed that patients from group A had jaundice (p<0.05) and altered sensorium (p<0.05) significantly more commonly as compared to those from group B and C. Serum sodium levels was not significantly associated with alcohol consumption. Among all examination findings, icterus (p<0.05) and clubbing (p<0.05) were found to be significantly more common among patients from group A, as compared to patients from group B or C. Pallor, pedal edema, signs of liver cell failure and organomegaly were not significantly associated with serum sodium levels in our study population. Hepatic encephalopathy (p<0.01), hepatorenal syndrome (p<0.01) and coagulopathy (p<0.01) were found to occur significantly more common among patients from group A, as compared to those in patients from group B or C. We also observed that mean direct bilirubin, alanine transaminase, aspartate transaminase and alkaline phosphatase were significantly higher among group A patients as compared to those from group B or C respectively. In addition, we observed that mean MELD (The Model for End-stage Liver Disease) score was significantly higher among group A patients (18.04+7.52) as compared to those with group B (13.24+5.02) and group C (12.04+4.72). We also observed that mean Child Pugh score (CPS) was significantly higher among group A patients (10.04+2.82) as compared to those with group B (8.72+1.45) and group C (7.34+2.02). Overall, 12% of the patients expired. Conclusion: Decompensated Chronic Liver Disease is associated with abnormal serum sodium concentration. Individuals with lower serum salt levels had a substantially higher MELD score and CPS. Furthermore, hepatic encephalopathy, hepatorenal syndrome, and coagulopathy were shown to be considerably more prevalent in individuals with blood sodium levels more than 136 mEq/l than in other patients.
Abstract (English)
Aim: To study the prevalence of hyponatremia in patients with chronic liver disease attending the outpatient department of a tertiary care hospital. Methodology: An observational cross-sectional study was conducted in the department of medicine, Darbhanga Medical College and Hospital, Darbhanga, Bihar for one year .In this study, patients in the age group of 18 to 65 years were included irrespective of gender, diagnosed with chronic liver disease. A history, physical examination, biochemical markers, ultrasonography, and upper gastrointestinal endoscopy were used to identify cirrhosis. Child-Turcotte Pugh score (CPS) and model for end stage liver disease (MELD) score was calculated for all patients [16]. Those with serum sodium levels less than or equal to 130 meq/l were classified as group A, those with serum sodium levels between 131-135 meq/l as group B and those with serum sodium levels greater than or equal to 136 meq/l as group C. Descriptive analysis of quantitative parameters was expressed as means and standard deviation. Results: In the present study, 100 patients were included. It was observed that 32% were in group A (≤ 130 mEq/l), 34% were in group B (131 to 135 mEq/l) and 34% were in group C (≥ 136 mEq/l). The age or gender of the patients was not associated with serum sodium levels. It was observed that patients from group A had jaundice (p<0.05) and altered sensorium (p<0.05) significantly more commonly as compared to those from group B and C. Serum sodium levels was not significantly associated with alcohol consumption. Among all examination findings, icterus (p<0.05) and clubbing (p<0.05) were found to be significantly more common among patients from group A, as compared to patients from group B or C. Pallor, pedal edema, signs of liver cell failure and organomegaly were not significantly associated with serum sodium levels in our study population. Hepatic encephalopathy (p<0.01), hepatorenal syndrome (p<0.01) and coagulopathy (p<0.01) were found to occur significantly more common among patients from group A, as compared to those in patients from group B or C. We also observed that mean direct bilirubin, alanine transaminase, aspartate transaminase and alkaline phosphatase were significantly higher among group A patients as compared to those from group B or C respectively. In addition, we observed that mean MELD (The Model for End-stage Liver Disease) score was significantly higher among group A patients (18.04+7.52) as compared to those with group B (13.24+5.02) and group C (12.04+4.72). We also observed that mean Child Pugh score (CPS) was significantly higher among group A patients (10.04+2.82) as compared to those with group B (8.72+1.45) and group C (7.34+2.02). Overall, 12% of the patients expired. Conclusion: Decompensated Chronic Liver Disease is associated with abnormal serum sodium concentration. Individuals with lower serum salt levels had a substantially higher MELD score and CPS. Furthermore, hepatic encephalopathy, hepatorenal syndrome, and coagulopathy were shown to be considerably more prevalent in individuals with blood sodium levels more than 136 mEq/l than in other patients.
Files
IJPCR,Vol14,Issue11,Article129.pdf
Files
(350.0 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:cc2d98a7f51b3ecf9596ae7b3b6557e3
|
350.0 kB | Preview Download |
Additional details
Dates
- Accepted
-
2022-10-25
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/14/IJPCR,Vol14,Issue11,Article129.pdf
- Development Status
- Active
References
- 1. Propst A, Propst T, Zangerl G, Ofner D, Judmaier G and Vogel W. Prognosis and life expectancy in chronic liver disease. Dig Dis Sci. 1995; 40(8):1805-1815. 2. James KS. India's demographic change: Opportunities and challenges. Science. 2011;333(6042):576-580. 3. Epstein M. Derangements of renal water handling in liver disease. Gastroenterology. 1985; 89:1415-1425 4. Arroyo V, Claria J, Salo J, Jime´nez W. Antidiuretic hormone and the pathogenesis of water retention in cirrhosis with ascites. Semin Liver Dis.1994; 14:44-58. 5. Gine`s P, Abraham W, Schrier RW. Vasopressin in pathophysiological states. SeminNephrol.1994;14:384-397 6. Arroyo V, Rodes J, GutierrezLizarraga MA. Prognostic value of spontaneous hyponatremia in cirrhosis with ascites. Dig Dis Sci. 1976;21:249 -256. 7. Gine`s P, Berl T, Bernardi M, Bichet DG, Hamon G, Jimenez W, et al. Hyponatremia in cirrhosis: from pathogenesis to treatment. Hepatology. 1998; 8:851-864. 8. Angeli P, Wong F, Watson H, Gines P. Hyponatremia in cirrhosis: results of a patient population survey. Hepatology. 2006; 44:1535-1542. 9. Heuman DM, Abou-Assi SG, Habib A, Williams LM, Strawitz RT, Sanyal AJ et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology. 2004; 40:802-810. 10. Fernandez-Esparrach G, SanchezFueyo A, Gines P, Uriz J, Quinto L, Ventura PJ et al. A prognostic model for predicting survival in cirrhosis with ascites. J Hepatol. 2001;34:46-52 11. Sanford E. Warren, MC; John A. Mitas II, MC; Aron H. R. Swerdlin, MC. Hypernatremia in Hepatic Failure. JAMA. 1980;243(12):1257- 1260. 12. Adrogué HJ and Madias NE. Hyponatremia. N Engl J Med. 2000; 342(21):1581-1589. 13. Attar B. Approach to Hyponatremia in Cirrhosis. Clin Liver Dis (Hoboken). 2019 Apr 30;13(4):98-101. 14. John S, Thuluvath PJ. Hyponatremia in cirrhosis: pathophysiology and management. World J Gastroenterol. 2015 Mar 21;21(11): 3197-205. 15. Ginès P, Guevara M. Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management. Hepatology. 2008 Sep; 48 (3):1002-10. 16. Child CG. Surgery and portal hypertension. The liver and portal hypertension. 1964:50-2. 17. Elkady MS, El-Toukhy NE, Rashed SE. Serum Sodium Concentration Profile in Cirrhotic Patients and its Effect on the Prognostic Value of the MELD Score. SAS J. Surg. 2016;2 (6) :266-77. 18. Umemura T, Shibata S, Sekiguchi T, Kitabatake H, Nozawa Y, Okuhara S et al. Serum sodium concentration is associated with increased risk of mortality in patients with compensated liver cirrhosis. Hepatol Res. 2015;45 (7):739-44.19. Jenq CC, Tsai MH, Tian YC, Chang MY, Lin CY, Lien JM et al. Serum sodium predicts prognosis in critically ill cirrhotic patients. J Clin Gastroenterol. 2010;44(3):220-6 20. Meganathan A and Kumar VS. Hyponatremia in cirrhosis- prevalence and correlation with the complications of cirrhosis. J Evol Med Dent Sci. 2018;7(18):2197-2202. 21. Kim JH, Lee JS, Lee SH, Bae WK, Kim NH, Kim KA, et al. The association between the serum sodium level and the severity of complications in liver cirrhosis. Korean J Intern Med. 2009;24(2):106112. 22. Borroni G., Maggi A., Sangiovanni A., Cazzaniga M, Salerno F. Clinical relevance of hyponatraemia for the hospital outcome of cirrhotic patients. Digestive and Liver Disease. 2000; 32: 605–610. 23. Porcel A, Diaz F, Rendón P, Macías M, Martín-Herrera L, GirónGonzález JA. Dilutional Hyponatraemia in Patients with Cirrhosis and Ascites. Archives of Internal Medicine. 2002; 162: 323–328. 24. Biggins S W, Rodriguez HJ, Bacchetti P, Bass NM., Roberts JP, Terrault NA. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology. 2005; 41:32–39. 25. Ruf A E, Kremers W, Chavez LL, Descalzi V I, Podesta LG, Villamil, F.G. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transplantation. 2005;11(3):33 6–343. 26. How to Cite Muñoz A. F. D., Ibrahim T. M., Ortiz C. T. N., Chávez Ángel F. L., Amaya G. P. B., Galvis M. C. C., Pacheco M. E. F., & Herrera M. A. I. Typical Mri Findings of Ramsay Hunt Syndrome. Journal of Medical Research and Health Sciences, 2022; 5(4): 1899–1905.